TGFB1 and Alzheimer disease: In conclusion, we found that CD1dhiPD-L1hiCD27+ was a unique TGF-β-producing NK subset and that treating such regulatory subset in a mouse AD disease model inhibited TH2-mediated effector cells and helped improve disease exacerbation.